We are live on ! Find out more
TTOO

T2 Biosystems, Inc
TTOO

Delisted

TTOO was delisted on the 11th of February, 2025.

Back to rankings

41 hedge funds and large institutions have $151M invested in T2 Biosystems, Inc in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

21% more call options, than puts

Call options by funds: $265K | Put options by funds: $219K

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

2% less capital invested

Capital invested by funds: $155M → $151M (-$3.78M)

15% less funds holding

Funds holding: 48 → 41 (-7)

60% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 10

Holders
41
Holders Change
-7
Holders Change %
-14.58%
% of All Funds
1.09%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
4
Increased
10
Reduced
5
Closed
10
Calls
$265K
Puts
$219K
Net Calls
+$46K
Net Calls Change
-$38K

Top Buyers

Rank Fund Capital Flow
1
LIM
Lagoda Investment Management
New York
+$3.02M
2
SM
Senvest Management
New York
+$1.64M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$526K
4
TM
Tiger Management
New York
+$427K
5
PVI
Pura Vida Investments
New York
+$394K

Top Sellers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
-$3.25M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.77M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.05M
4
SIM
Spark Investment Management
New York
-$791K
5
EIM
Essex Investment Management
Massachusetts
-$624K
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$157K – – –
TA
27
Teachers Advisors
New York
$145K – – –
Deutsche Bank
28
Deutsche Bank
Germany
$104K – – –
RFS
29
Rockefeller Financial Services
New York
$85K – – –
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$79K – – –
NFA
31
Nationwide Fund Advisors
Ohio
$65K – – –
BA
32
BlackRock Advisors
Delaware
$62K +$32.8K +1 +100%
AIG
33
American International Group
New York
$61K – – –
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
$60K – – –
TWA
35
TCI Wealth Advisors
Arizona
$35K – – –
Manulife (Manufacturers Life Insurance)
36
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$30K – – –
PNC Financial Services Group
37
PNC Financial Services Group
Pennsylvania
$28K – – –
UBS Group
38
UBS Group
Switzerland
$27K -$263K -8 -89%
Citigroup
39
Citigroup
New York
$26K +$32.8K +1 New
Wells Fargo
40
Wells Fargo
California
$22K – – –
CG
41
Cutler Group
California
$9K – – –
SSB
42
Sandy Spring Bank
Maryland
$7K – – –
BNP Paribas Financial Markets
43
BNP Paribas Financial Markets
France
$6.85K – – –
BlackRock
44
BlackRock
New York
$6K – – –
Bank of America
45
Bank of America
North Carolina
$5K – – –
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
$3K – – –
AG
47
Advisor Group
Arizona
$1K – – –
Barclays
48
Barclays
United Kingdom
$1K – – –
First Manhattan
49
First Manhattan
New York
$1K – – –
MAM
50
Meeder Asset Management
Ohio
$1K – – –
1
2
3

TTOO Hedge Fund Activity: Q3 2016 in Review

41 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2016, worth a combined $151M — down 2.4% from $155M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of TTOO and 4 opened new positions — a net loss of 6 holders — while 5 trimmed existing stakes and 10 added.

The largest buyer was Lagoda Investment Management, adding an estimated $3.02M. The largest seller was Gilder Gagnon Howe & Co, exiting entirely with an estimated $3.25M sold.

  • 41 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2016, down from 48 in Q2 2016.
  • Funds reported $151M of T2 Biosystems, Inc stock for Q3 2016, down 2.4% quarter-over-quarter.
  • 4 funds opened new T2 Biosystems, Inc positions in Q3 2016 and 10 closed out, a net change of -6 holders.
  • The largest T2 Biosystems, Inc buyer in Q3 2016 was Lagoda Investment Management, an estimated $3.02M added.
  • The largest T2 Biosystems, Inc seller in Q3 2016 was Gilder Gagnon Howe & Co, an estimated $3.25M sold.

Based on aggregated 13F filings for Q3 2016.